Clinical Trials Logo
  1. Home
  2. Acute Otitis Media
  3. NCT01214538
  4. Details
NCT01214538 Clinical Trial

Assessment of the Natural Antibody Response to Pneumococcal Surface Proteins During Acute Otitis Media in Children

Acute Otitis Media Clinical Trial

Official title:
Assessment of the Natural Antibody Response to Pneumococcal Surface Proteins During Acute Otitis Media in Children

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT01214538
Other study ID # NX10-07
Secondary ID
Status Recruiting
Phase N/A
First received October 3, 2010
Last updated September 26, 2011
Start date October 2010
Est. completion date July 2014

Study information
Verified date September 2011
Source NasVax Ltd
Contact n/a
Is FDA regulated No
Health authority Israel: Ministry of Health
Study type Observational

Clinical Trial Summary

This clinical study is designed to assess prospectively the sero-responses to various proteins in cases of pneumococcal Acute Otitis Media.

Recruitment information / eligibility
Status Recruiting
Enrollment 100
Est. completion date July 2014
Est. primary completion date March 2014
Accepts healthy volunteers No
Gender Both
Age group 3 Months to 3 Years
Eligibility Inclusion Criteria:

- Male and female Jewish and Bedouin children.

- Patients can be either ambulatory or hospitalized.

- Presenting with acute otitis media.

- Tympanocentesis was performed at least in one ear for a clinical indication.

- Culture of middle ear fluid was obtained.

- Parents agreeing to participate in the study and to submit their children for follow-up, blood test and nasopharyngeal/oropharyngeal (NP/OP) cultures.

Exclusion Criteria:

- Having another infection that is likely to be caused by S. pneumoniae.

- Known immunodeficiency.

- Known previous recent pneumococcal infections (<1 month prior to current visit).

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

Locations
Country Name City State
Israel Ben-Gurion University of the Negev Beer Sheva

Sponsors (1)
Lead Sponsor Collaborator
NasVax Ltd

Country where clinical trial is conducted

Israel, 

Outcome
Type Measure Description Time frame Safety issue
Primary Serological studies of pneumococcal proteins and their development over time following otitis media infections The serological studies will study the natural immune response to protective pneumococcal vaccine antigens. 3 months per individual No
See also
  Status Clinical Trial Phase
Completed NCT02092454 - Study to Assess the Safety and Efficacy of Benzocaine for Pain Relief in Children Presenting With Acute Otitis Media Phase 2
Completed NCT01202578 - Evaluation of the Tympanostomy Tube Delivery System Phase 2/Phase 3
Withdrawn NCT00502450 - Is There Hearing Loss After Acute Mastoiditis N/A
Completed NCT04296448 - Evaluation of Cellphone Based Otoscopy in Pediatric Patients N/A
Terminated NCT05651633 - Analgesic Ear Drops for Children With Acute Otitis Media Phase 3
Completed NCT02345447 - Herbal-Based Medication vs. Placebo in Preventing Acute Otitis Media in Children at High Risk of Recurrence Phase 3
Completed NCT01941381 - Does Tympanometry Predict Antibiotic Usage in Acute Otitis Media?
Completed NCT03614117 - Effect of a New Probiotic Strain on Recurrent Acute Otitis Media in Children (PROMAR) N/A
Recruiting NCT06027593 - Using Electronically Derived Automated Reports of Appropriate Antibiotic Use to Inform Stewardship Interventions N/A
Completed NCT02918773 - Pediatric Emergency Department Smartphone Otoscope Study (PED-Oto) N/A
Completed NCT02567747 - Vaccination Impact Against Pneumococcal Disease on Acute Otitis Media Morbidity in Colombian Children < 5 Years of Age
Completed NCT02935374 - Effect of Antimicrobial Treatment of Acute Otitis Media on the Intestinal Microbiome in Children Phase 4
Completed NCT02567825 - Efficacy of Tympanostomy Tubes for Children With Recurrent Acute Otitis Media N/A
Completed NCT02037893 - Four Arm Safety & Efficacy With Antipyrine and Benzocaine Otic Solution in Children With Acute Otitis Media Phase 2
Completed NCT00578773 - A Phase II Study of an Otic Formulation in Treating Peri-Operative Tube Otorrhea Phase 2
Completed NCT00377260 - Acute Otitis Media (AOM) Therapy Trial in Young Children Phase 4
Completed NCT00645112 - A Comparison of Safety and Efficacy of Cefdinir Oral Suspension Versus Azithromycin in Pediatric Subjects With Acute Otitis Media Phase 4
Completed NCT00368823 - A Trial of Point of Care Information in Ambulatory Pediatrics Phase 3
Completed NCT01272999 - Impact of Prevnar 13 on Ear Infections in Children
Completed NCT01031082 - Study to Identify and Characterize Bacteria Causing Acute Otitis Media in South African Children N/A